Treatment of children with refractory/relapse high risk langerhans cell histiocytosis with the combination of cytarabine, vindesine and prednisone

• Hauptverfasser: Wenqian Wang (Verfasst von), Jian Ge (Verfasst von), Honghao Ma (Verfasst von), Hongyun Lian (Verfasst von), Lei Cui (Verfasst von), Yunze Zhao (Verfasst von), Zhigang Li (Verfasst von), Tianyou Wang (Verfasst von), Rui Zhang (Verfasst von)
• Format: Buch
• Veröffentlicht: BMC, 2024-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Abstract Background The patients with multisystem and risk organ involvement Langerhans cell histiocytosis (MS-RO + LCH) have poor prognosis. The patients with MS-LCH who failed front-line therapy have a high mortality rate and the standard salvage treatment has not been established. The combination...